Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers

Breast Cancer Research and Treatment

Volumn 136, Issue 1, 2012, Pages 295-302

  Stevens, Kristen N ^a   Wang, Xianshu ^a   Fredericksen, Zachary ^a   Pankratz, Vernon S ^a   Greene, Mark H ^b   Andrulis, Irene L ^c,d,e   Thomassen, Mads ^f   Caligo, Maria ^g   Nathanson, Katherine L ^h   Jakubowska, Anna ⁱ   Osorio, Ana ^j,k   Hamann, Ute ^l   Godwin, Andrew K ^m   Stoppa Lyonnet, Dominique ^n,o   Southey, Melissa ^p   Buys, Saundra S ^q   Singer, Christian F ^r   Hansen, Thomas V O ^s   Arason, Adalgeir ^t,u   Offit, Kenneth ^v   Piedmonte, Marion ^w   Montagna, Marco ^x   Imyanitov, Evgeny ^y   Tihomirova, Laima ^z   Sucheston, Lara ^w   Beattie, Mary ^aa   Neuhausen, Susan L ^ab   Szabo, Csilla I ^ac   Simard, Jacques ^ae   Spurdle, Amanda B ^ad,af   Healey, Sue ^af   Chen, Xiaoqing ^af   Rebbeck, Timothy R ^ag   Easton, Douglas F ^ah   Chenevix Trench, Georgia ^af   Antoniou, Antonis C ^ah   Couch, Fergus J ^a   more..

^a MAYO CLINIC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CANCER CARE ONTARIO   (Canada)

^d MOUNT SINAI HOSPITAL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ POMERANIAN MEDICAL UNIVERSITY   (Poland)

^j Centro Nacional de Investigaciones Oncológicas   (Spain)

^k CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

ⁿ INSERM   (France)

^o Fédération Nationale des Centres de Lutte Contre le Cancer   (France)

^p UNIVERSITY OF MELBOURNE   (Australia)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^r UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^s Rigshospitalet   (Denmark)

^t Copenhagen University Hospital ^*  (Iceland)

^u UNIVERSITY OF ICELAND   (Iceland)

^v MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^w ROSWELL PARK CANCER INSTITUTE   (United States)

^x VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^y N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^z LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^aa UNIVERSITY OF CALIFORNIA   (United States)

^ab CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^ac UNIVERSITY OF DELAWARE   (United States)

^ad PETER MACCALLUM CANCER CENTRE   (Australia)

^ae LAVAL UNIVERSITY   (Canada)

^af QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^ag BELFAST CITY HOSPITAL   (United Kingdom)

^ah UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Association study; BRCA1; BRCA2; Genetic modifier

Indexed keywords

ALLELE; ARTICLE; BREAST CANCER; CHROMOSOME 6P; CHROMOSOME 6P22; FOLLOW UP; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MASTECTOMY; OVARY CANCER; PRIORITY JOURNAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84867845983     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2255-6     Document Type: Article

References (11)

1. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T et al (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42(10):885-892
2. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segre AV, McGee K, McGuffog L, Kartsonaki C et al (2010) Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 6(10):e1001183
3. Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S et al (2010) Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 19(14):2886-2897
4. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X et al (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 18(22):4442-4456
5. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70(23):9742-9754
6. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82(4):937-948
7. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B et al (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 20(16):3304-3321
8. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM et al (2012) Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res 14(1):R33
9. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, Easton DF (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29(1):1-11
10. Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R, Nogues C et al (2009) Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev 18(2):601-610
11. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616-1622